Role of COVID-19 Vaccination for SARS-CoV-2 Infection
Risk of reporting symptoms for 28 or more days after COVID-19 onset was significantly higher in participants who were unvaccinated at the time of infection and those who reported moderate or severe acute illness symptoms as per a study of 1,832 U.S. adults published in the journal JAMA Network Open.
At six months after onset, participants had significantly higher risk of pulmonary, diabetes, neurological, and mental health encounters versus pre-infection baseline.
‘Risk of acquiring various illnesses was found to be higher, six months after the onset of the COVID-19 symptoms, and getting vaccinated may help attenuate the risk. ’
Addressing the Post-COVID-19 Symptoms
The present study explores the factors associated with persistent post-COVID-19 symptoms, and how do post-COVID-19 medical encounters change over time.This was a cohort study used data from the Epidemiology, Immunology, and Clinical Characteristics of Emerging Infectious Diseases With Pandemic Potential (EPICC) study implemented in the US military health system (MHS); MHS beneficiaries aged 18 years or older who tested positive for SARS-CoV-2 from February 28, 2020, through December 31, 2021, were analyzed, with 1-year follow-up.
The study thereby helps identify characteristics associated with persistent post-COVID-19 symptoms and to describe post-COVID-19 medical encounters. The findings may also help inform the risk-benefit ratio of the COVID-19 vaccination policy.
Source: Eurekalert